ライフサイエンスコーパス: agouti-related peptide

1 timulating neuropeptides, neuropeptide Y and Agouti-related peptide.

2 The orexigenic peptide Agouti Related Peptide (AgRP) also produces hyperphagia

3 hypothalamus (ARH) that contains orexigenic agouti-related peptide (AgRP) and anorexigenic pro-opiom

4 g-responsive hypothalamic neurons expressing agouti-related peptide (AgRP) and neuropeptide Y (Npy).

5 Agouti-related peptide (AGRP) and Neuropeptide Y are pot

6 w leptin-sensing neuron population, multiple agouti-related peptide (AgRP) and pro-opiomelanocortin (

7 Hypothalamic neurons expressing Agouti-related peptide (AgRP) are critical for initiatin

8 te time periods, and measured the density of Agouti-Related Peptide (AgRP) containing projections fro

9 ing view is that the orexigenic neuropeptide agouti-related peptide (AgRP) exerts the opposite action

10 lanocortin (POMC), neuropeptide Y (NPY), and agouti-related peptide (AGRP) expression.

11 ivate or inhibit ArcN NPY neurons expressing agouti-related peptide (AgRP) in mice, we have demonstra

12 Expression of agouti-related peptide (AGRP) in the hypothalamus is inc

13 Agouti-related peptide (AgRP) is a naturally occurring M

14 M glucose concentrations, more inhibition of agouti-related peptide (AgRP) mRNA and AMP-activated pro

15 ortin (POMC) mRNA and increased hypothalamic agouti-related peptide (AGRP) mRNA and neuropeptide Y (N

16 d fasting on pro-opiomelanocortin (POMC) and agouti-related peptide (AgRP) mRNA levels in the hypotha

17 ine leptin inhibits neuropeptide Y (NPY) and agouti-related peptide (AgRP) neuronal activity, resulti

18 Hypothalamic Agouti-related peptide (AgRP) neurons are critical regul

19 Agouti-related peptide (AgRP) neurons in the arcuate nuc

20 Agouti-related peptide (AgRP) neurons in the arcuate nuc

21 Agouti-related peptide (AgRP) neurons of the arcuate nuc

22 Agouti-related peptide (AgRP) neurons of the hypothalamu

23 hysiologic regulation.SIGNIFICANCE STATEMENT Agouti-related peptide (AgRP) neurons play an important

24 Activation of Agouti-related peptide (AgRP) neurons potently promotes

25 Hypothalamic agouti-related peptide (AgRP) neurons potently stimulate

26 ns, including proopiomelanocortin (POMC) and agouti-related peptide (AgRP) neurons, also release amin

27 ns, including proopiomelanocortin (POMC) and agouti-related peptide (AgRP) neurons, also release amin

28 ic proopiomelanocortin (POMC) and orexigenic agouti-related peptide (AgRP) neurons, electrophysiologi

29 as recently reported to be a Foxo1 target in agouti-related peptide (AGRP) neurons.

30 eurons [e.g., proopiomelanocortin (POMC) and agouti-related peptide (AgRP) neurons], and as a result,

31 euron populations specified by expression of agouti-related peptide (AGRP) or pro-opiomelanocortin (P

32 Hypothalamic neurons expressing agouti-related peptide (AgRP) regulate eating and glucos

33 Syndecans potently modulate agouti-related peptide (AgRP) signaling in the central m

34 conversely, administration of the antagonist Agouti-related peptide (Agrp) to wild-type mice enhanced

35 neurons expressing neuropeptide Y (NPY) and agouti-related peptide (AgRP) via GABA-dependent signali

36 gnaling from hypothalamic neurons expressing agouti-related peptide (AgRP) was genetically inactivate

37 of hypothalamic 'hunger neurons' (expressing agouti-related peptide (AgRP)) bypasses these signals to

38 (alpha-MSH), an endogenous MC4R agonist, and agouti-related peptide (Agrp), an endogenous MC4R antago

39 Expression of 3 neuropeptide genes, agouti-related peptide (Agrp), neuropeptide Y (Npy), and

40 lanocyte stimulating hormone (alpha-MSH) and agouti-related peptide (AGRP), on feeding behavior and e

41 iomelanocortin (POMC), neuropeptide Y (NPY), agouti-related peptide (AGRP), somatostatin, and dopamin

42 a-MSH) and to an antagonist/inverse agonist, agouti-related peptide (AgRP), which are released by ups

43 ific Cre-driver mice to reexpress RIIbeta in agouti-related peptide (AgRP)-, proopiomelanocortin (POM

44 es the activity of neuropeptide Y (NPY)- and agouti-related peptide (AgRP)-co-producing (NPY/AgRP) ne

45 Agouti-related peptide (AgRP)-expressing neurons are act

46 Hypothalamic agouti-related peptide (AgRP)-expressing neurons are cri

47 expressing and hunger signaling (orexigenic) agouti-related peptide (AgRP)-expressing neurons are key

48 Agouti-related peptide (AgRP)-expressing neurons in the

49 Agouti-related peptide (AgRP)-expressing neurons in the

50 Pro-opiomelanocortin (POMC)- and agouti-related peptide (AgRP)-expressing neurons of the

51 occurred primarily within neurons expressing agouti-related peptide (AgRP).

52 melanin-stimulating hormone (alpha-MSH), and agouti-related peptide (AgRP).

53 se expressing proopiomelanocortin (POMC) and agouti-related peptides (AgRP).

54 Agouti-related-peptide (AgRP) neurons-interoceptive neur

55 hibition of neural melanocortin receptors by agouti-related peptide also attenuated rhythmicity in th

56 A expression of the orexigenic neuropeptides Agouti-related peptide and melanin-concentrating hormone

57 kinase kinase beta or AMPK greatly increases Agouti-related peptide and melanin-concentrating hormone

58 e excited orexigenic neurons that synthesize agouti-related peptide and neuropeptide Y but inhibited

59 striction, MSI-1436 decreased mRNA levels of agouti-related peptide and neuropeptide Y in the hypotha

60 Neurons coexpressing neuropeptide Y, agouti-related peptide, and GABA (NAG) play an important

61 Hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocoritin (POMC)

62 subsets (proopiomelanocortin, neuropeptide Y/agouti-related peptide, and steroidogenic factor 1), tho

63 coadministration of the alpha-MSH antagonist agouti-related peptide blocked the anorexigenic effects

64 This analysis revealed that CFLIR in agouti related peptide-expressing orexigenic ARC neurons

65 knockdown of Sirtuin 1 Sirt1 in hypothalamic Agouti-related peptide-expressing neurons, which renders

66 2-null mice, while the density of orexigenic agouti-related peptide fibers in the mutant mice appeare

67 ding those producing pro-opiolemelanocortin, agouti-related peptide, hypocretin/orexin, melanin-conce

68 des proopiomelanocortin, neuropeptide Y, and agouti-related peptide in T1D mice.

69 increased pro-opiomelanocortin and decreased agouti-related peptide in the hypothalamus.

70 t on brain systems utilizing neuropeptide Y, agouti-related peptide, melanocortins, orexins, and mela

71 and prevents starvation in adult mice whose agouti-related peptide neurons are ablated.

72 ause starvation after ablation of orexigenic agouti-related peptide neurons in adult mice.

73 increase in the appetite-regulating proteins agouti-related peptide, neuropeptide Y, and uncoupling p

74 vity, and expression of pro-opiomelanocortin/agouti-related peptide/neuropeptide Y in the hypothalamu

75 etrogradely labeled neurons contained either agouti-related peptide or cocaine/amphetamine-regulated

76 ne or hypothalamic levels of neuropeptide Y, agouti-related peptide, pro-opiomelanocortin, or cocaine

77 several hypothalamic neuropeptides, notably agouti-related peptide, proopiomelanocortin, and neurope

78 ice administered the MC3-R/MC4-R antagonist, agouti-related peptide, resist tumor-induced loss of lea

79 ter (that controlling the Agrp gene encoding agouti-related peptide) responsive to BDNF-induced physi

80 wise, treatment of WT mice with intracranial agouti-related peptide reversed the cachexic effects of